Genomic Health, Inc.(GHDX – Analyst Report) recently declared that Medicare contractor, Palmetto GBA, has issued a draft local coverage determination (LCD) for its Oncotype DX prostate cancer test. The draft LCD recommends coverage and reimbursement of the Oncotype DX prostate cancer test for applicable Medicare patients across the U.S. This should encourage the identification of…
International study of advanced prostate cancer genome finds abundance of potential targets for drug therapy The first major effort to canvas the genomic landscape of advanced prostate cancer has revealed that many patients may carry some type of genetic abnormality that can be targeted with existing or potential drugs. The finding, reported today by a…
AdMeTech Foundation Joins Senator Harriette Chandler, Mosaic and Barbershop Health Network to Raise Awareness WORCESTER, MA, May 15, 2015—AdMeTech Foundation will support and participate in the “Saving Our Men Symposium” on Sunday in coordination with Mosaic Cultural Complex, which created Barbershop Health Network to educate men of color about screening and early detection of preventable…
Importance of Baseline Screening in Younger Men is Underscored NEWTON, MA, May 15, 2015—AdMeTech Foundation and the Massachusetts Prostate Cancer Coalition (MPCC) today led the state’s first public discussion of the Clinical Practice Guidelines for Early Detection of Prostate Cancer developed by the National Comprehensive Cancer Network (NCCN). These guidelines were developed by the world-leading…